NCT00210262View on ClinicalTrials.gov

Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes

NACompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

January 31, 2005

Conditions
Diabetes
Interventions
BEHAVIORAL

Feedback and Education

Trial Locations (1)

Unknown

ICES, Toronto

All Listed Sponsors
lead

Institute for Clinical Evaluative Sciences

OTHER

NCT00210262 - Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes | Biotech Hunter | Biotech Hunter